Literature DB >> 23157634

Proton magnetic resonance spectroscopy changes after antipsychotic treatment.

Agata Szulc1, Beata Galinska-Skok, Napoleon Waszkiewicz, Daniel Bibulowicz, Beata Konarzewska, Eugeniusz Tarasow.   

Abstract

Proton magnetic resonance spectroscopy ((1)H MRS) enables the observation of brain function in vivo. Several brain metabolites can be measured by the means of (1)H MRS: N-acetylaspartate (NAA), choline containing compounds (Cho), myo-inositol (mI) and glutamate (Glu), glutamine (Gln) and GABA (together as Glx complex or separately). (1)H MRS measures have been found to be abnormal in psychotic disorders such as schizophrenia. Here we specifically review the influence exerted by antipsychotic drugs on brain metabolism, as detected by (1)H MRS. We systematically reviewed the available literature and uncovered 27 studies, 16 before-after treatment and 11 cross-sectional. Most of them addressed the effects of antipsychotics in schizophrenia and mainly focusing on NAA alterations. Follow up studies indicated antipsychotic drugs may act by increasing NAA levels in selected brain areas (the frontal lobe and thalamus), especially during the short-time observation. This phenomenon seems to vanish after longer observation. Other studies indicated that glutamate measures are decreasing along with the duration of the disease, suggesting both a neurodegenerative process present in schizophrenic brain as well as an influence of antipsychotics. The above results were reviewed according to the most recent theories in the field accounting for the impact of antipsychotics (1)HMRS measures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23157634

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  14 in total

1.  Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens.

Authors:  Su Xu; Rao P Gullapalli; Douglas O Frost
Journal:  Schizophr Res       Date:  2014-12-05       Impact factor: 4.939

2.  Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study.

Authors:  M I Atagün; E M Şıkoğlu; S S Can; G Karakaş-Uğurlu; S Ulusoy-Kaymak; A Çayköylü; O Algın; M L Phillips; C M Moore; D Öngür
Journal:  Schizophr Res       Date:  2014-12-03       Impact factor: 4.939

3.  Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia.

Authors:  Xujun Duan; Maolin Hu; Xinyue Huang; Chan Su; Xiaofen Zong; Xia Dong; Changchun He; Jinming Xiao; Haoru Li; Jinsong Tang; Xiaogang Chen; Huafu Chen
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

4.  N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia.

Authors:  Marine Mondino; Jerome Brunelin; Mohamed Saoud
Journal:  Front Psychiatry       Date:  2013-09-05       Impact factor: 4.157

5.  Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.

Authors:  Meghan Elizabeth Goldstein; Valerie Margaret Anderson; Avinesh Pillai; Robert R Kydd; Bruce R Russell
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-20       Impact factor: 5.176

6.  The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study.

Authors:  Vladimir Grošić; Petra Folnegović Grošić; Petra Kalember; Maja Bajs Janović; Marko Radoš; Mate Mihanović; Neven Henigsberg
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-07       Impact factor: 2.570

7.  Comparison of inter subject variability and reproducibility of whole brain proton spectroscopy.

Authors:  Tonny V Veenith; Marius Mada; Eleanor Carter; Julia Grossac; Virginia Newcombe; Joanne Outtrim; Victoria Lupson; Sridhar Nallapareddy; Guy B Williams; Sulaiman Sheriff; David K Menon; Andrew A Maudsley; Jonathan P Coles
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

8.  Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.

Authors:  Edith Liemburg; Anita Sibeijn-Kuiper; Leonie Bais; Gerdina Pijnenborg; Henderikus Knegtering; Jorien van der Velde; Esther Opmeer; Annerieke de Vos; Jozarni Dlabac-De Lange; Lex Wunderink; André Aleman
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

9.  Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.

Authors:  James M Stone; Fiona Pepper; Johnson Fam; Hannah Furby; Emer Hughes; Celia Morgan; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

10.  Tracking the neuroplastic changes associated with transcranial direct current stimulation: a push for multimodal imaging.

Authors:  Michael A Hunter; Brian A Coffman; Michael C Trumbo; Vincent P Clark
Journal:  Front Hum Neurosci       Date:  2013-08-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.